XML 30 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2012
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition

The Company is a party to research and development contracts with the Federal government to develop certain technology to be utilized by the US Department of Defense. The contracts are cost plus fixed fee contracts and revenue is recognized based on the extent of progress towards completion of the long term contract.

The Company generally uses a variation of the cost to cost method to measure progress for all long term contracts unless it believes another method more clearly measures progress towards completion of the contract.

Revenues are recognized as costs are incurred and include estimated earned fees, or profit, calculated on the basis of the relationship between costs incurred and total estimated costs at completion.  Under the terms of certain contracts, fixed fees are not recognized until the receipt of full payment has become unconditional, that is, when the product has been delivered and accepted by the Federal government.  Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts as work is performed.  The Company’s backlog primarily consists of future Adaptive Diagnostic Electronic Portable Testset (“ADEPT”) units to be developed and delivered to the Federal government.  The estimated value of the ADEPT® units and the Small Business Innovative Research (“SBIR”) program backlog was $3,292,568 as of September 30, 2012.

Unbilled revenue reflects work performed, but not billed at the time, per contractual requirements. As of September 30, 2012 and December 31, 2011, the Company had no unbilled revenues.  Billings to customers in excess of revenue earned are classified as advanced billings, and shown as a liability.  As of September 30, 2012 and December 31, 2011, the Company had no advanced billings.  Under the Indefinite-Delivery, Indefinite-Quantity (“IDIQ”) agreement, the Company delivered 36 units for the nine months ended September 30, 2012
Standard Product Warranty, Policy [Policy Text Block]
Warranty Expense

The Company provides a limited warranty, as defined by the related warranty agreements, for its production units.  The Company’s warranties require the Company to repair or replace defective products during such warranty period. The Company estimates the costs that may be incurred under its warranty and records a liability in the amount of such costs at the time product revenue is recognized. Factors that affect the Company’s warranty liability include the number of units sold, expected and anticipated rates of warranty claims, and cost per claim. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amount as necessary.  During the three and nine months ended September 30, 2012, the Company reversed warranty expenses of $24,500 and $32,400, respectively.   Since the inception of the IDIQ contract in March 2010, the Company has delivered 81 ADEPT units.  As of September 30, 2012, there are 38 ADEPT units that remain under the limited warranty coverage.  As of September 30, 2012 and December 31, 2011, the Company had an accrued warranty expense of $52,338 and $86,400, respectively
Research, Development, and Computer Software, Policy [Policy Text Block]
Research and Development Costs

Research and Development expenditures for research and development of the Company's products are expensed when incurred, and are included in general and administrative expenses. The Company recognized research and development costs of $21,809 and $8,794 for the three months ended September 30, 2012 and 2011, respectively, and $49,547 and $34,761 for the nine months ended September 30, 2012 and 2011, respectively
Intangible Assets, Finite-Lived, Policy [Policy Text Block]
Patents and Trademarks

The Company has developed and continues to develop intellectual property (technology and data) under SBIR and other contracts.  The request for a trademark for the product name “ADEPT” has been approved by the U.S. Patent and Trademark Office, and ADEPT® is now a registered trademark of the Company.

Under SBIR data rights, the Company is protected from unauthorized use of SBIR-developed technology and data for a period of five years after acceptance of all items to be delivered under a particular SBIR contract or any follow-on contract.

During the nine months ended September 30, 2012, the Company discontinued the use of certain technology and related patents.  The Company removed the historical carrying value of these patents of $4,000 from its condensed balance sheet as of September 30, 2012 and immediately recognized $2,933 of unamortized balance as amortization expense for the nine months ended September 30, 2012